Korsana Biosciences cash flow statement data for the quarter ended Dec 2025. This cash flow statement covers 32 quarters of results from Mar 2018 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||||||
| Net Income | -13.39M | -16.18M | -11.29M | -14.34M | -12.98M | -13.43M | -10.50M | -7.22M | -6.95M | -4.18M | 7.57M | -1.69M | -1.54M | -1.32M | -0.72M | 0.53M | -1.46M | -1.67M | -1.01M | |||||||||||||
| Share-based CompensationStock Comp. | 2.31M | 2.34M | 2.41M | 2.55M | 1.77M | 1.70M | 1.66M | 1.12M | 0.43M | 0.38M | 0.16M | 0.10M | 0.18M | 0.18M | 0.14M | 0.12M | 0.11M | 0.11M | 0.12M | |||||||||||||
| Gains from Sales and DivestituresGains Divest | 0.01M | -6.33M | ||||||||||||||||||||||||||||||
| Asset Writedowns and ImpairmentWritedown | 3.30M | |||||||||||||||||||||||||||||||
| Cash from OperationsCash from Ops. | -14.46M | -5.51M | -7.92M | -8.63M | -12.84M | -10.82M | -9.91M | -7.04M | -6.21M | -6.55M | -6.93M | -1.54M | -1.87M | -1.11M | -1.72M | 0.36M | -0.97M | -0.50M | -0.26M | |||||||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.26M | 0.10M | 0.60M | 0.05M | 0.05M | 0.02M | ||||||||||||||||||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | 0.16M | -0.06M | 0.13M | -0.13M | -0.10M | 0.56M | 0.03M | -0.06M | -0.42M | |||||||||||||||||||||||
| Change in Account PayablesChange Payables | -0.29M | 0.96M | 0.69M | 0.25M | -1.12M | 1.32M | 0.95M | -2.06M | -1.05M | 0.39M | -0.46M | -0.09M | 0.02M | 0.09M | 0.09M | -0.02M | 0.02M | |||||||||||||||
| Change in Accured ExpensesChange Accured Exp. | -3.44M | -0.48M | -0.14M | -0.28M | -0.47M | -0.11M | 0.24M | -0.19M | -0.38M | 0.46M | -1.30M | -0.37M | -0.19M | -0.08M | -0.21M | -0.04M | 0.12M | -0.14M | 0.09M | |||||||||||||
| Other Working Capital ChangesOther WC Changes | -0.77M | -0.27M | -0.21M | 0.01M | -0.09M | -0.19M | -0.11M | 0.03M | -0.24M | 0.48M | -0.45M | -0.15M | -0.13M | -0.19M | 0.51M | -0.20M | -0.17M | 0.21M | -0.08M | |||||||||||||
| Investing Activities | ||||||||||||||||||||||||||||||||
| Capital ExpendituresCapex | ||||||||||||||||||||||||||||||||
| Sales of Property, Plant and EquipmentPP&E (Sale) | 1.46M | 0.00M | ||||||||||||||||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | 1.46M | 0.00M | -0.01M | 10.40M | ||||||||||||||||||||||||||||
| Financing Activities | ||||||||||||||||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 0.03M | 30.63M | 0.04M | 0.09M | 0.02M | 0.01M | 1.38M | -0.13M | 1.83M | |||||||||||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 0.03M | 30.47M | 0.01M | 0.02M | 0.01M | 1.38M | 0.72M | |||||||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||
| Exchange Rate EffectFX Effect | 0.00M | 0.00M | -0.00M | -0.00M | -0.00M | 0.01M | 0.00M | 0.00M | 0.00M | -0.00M | -0.00M | |||||||||||||||||||||
| Change in Cash | -12.97M | 25.12M | -7.89M | -8.54M | -12.84M | -10.80M | -9.92M | -7.02M | -6.21M | -1.53M | 3.47M | -1.54M | -1.88M | -1.11M | -1.72M | 0.36M | 0.41M | -0.63M | 1.56M | |||||||||||||
| Free Cash FlowFCF | -14.46M | -5.51M | -7.92M | -8.63M | -12.84M | -10.82M | -9.91M | -7.04M | -6.21M | -6.55M | -6.93M | -1.54M | -1.87M | -1.11M | -1.72M | 0.36M | -0.97M | -0.50M | -0.26M | |||||||||||||
| Net Cash FlowNCF | -12.97M | 25.12M | -7.89M | -8.54M | -12.84M | -10.80M | -9.91M | -7.03M | -6.21M | -6.55M | 3.47M | -1.54M | -1.87M | -1.11M | -1.72M | 0.36M | 0.41M | -0.63M | 1.56M |
Pull Korsana Biosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=KRSA&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "KRSA", "statement": "CF", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=KRSA&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();